MRI findings in people with epilepsy and nodding syndrome in an area endemic for onchocerciasis: An observational study by Winkler, AS et al.
African Health Sciences Vol 13  Issue 2 June  2013 529
MRI findings in people with epilepsy and nodding syndrome in
an area endemic for onchocerciasis: an observational study
*Winkler AS1,2, Friedrich K3, Velicheti S4, Dharsee J4, König R3, Nassri A3, Meindl M3, Kidunda A5, Müller
TH6, Jilek-Aall L7, Matuja W8, Gotwald T9, Schmutzhard E3
1. Department of  Neurology, Technical University of  Munich, Germany
2. Haydom Lutheran Hospital, Manyara Region, Tanzania
3. Department of  Neurology, Medical University of  Innsbruck, Innsbruck, Austria
4. Department of  Radiology, The Aga Khan Hospital, Dar es Salaam, Tanzania
5. Mahenge District Hospital, Morogoro Region, Tanzania
6. Institute for Medical Informatics, Biometry and Epidemiolgy, Ludwig-Maximilians-University, Munich,
Germany
7. Department of  Psychiatry, University of  British Columbia, Vancouver, Canada
8. Department of  Neurology, Muhimbili University of  Health and Allied Sciences, Dar es Salaam, Tanzania
9. Department of  Radiology, Medical University of  Innsbruck, Innsbruck, Austria
 
Abstract
Background: Onchocerciasis has been implicated in the pathogenesis of  epilepsy. The debate on a potential causal relationship
between Onchocerca volvulus and epilepsy has taken a new direction in the light of the most recent epidemic of nodding
syndrome.
Objective: To document MRI changes in people with different types of  epilepsy and investigate whether there is an
association with O. volvulus infection.
Methods: In a prospective study in southern Tanzania, an area endemic for O. volvulus with a high prevalence of  epilepsy and
nodding syndrome, we performed MRI on 32 people with epilepsy, 12 of  which suffered from nodding syndrome.
Polymerase chain reaction (PCR) of  O. volvulus was performed in skin and CSF.
Results: The most frequent abnormalities seen on MRI was atrophy (twelve patients (37.5%)) followed by intraparenchymal
pathologies such as changes in the hippocampus (nine patients (28.1%)), gliotic lesions (six patients (18.8%)) and subcortical
signal abnormalities (three patients (9.4%)). There was an overall trend towards an association of intraparenchymal cerebral
pathologies and infection with O. volvulus based on skin PCR (Fisher’s Exact Test p=0.067) which was most pronounced in
children and adolescents with nodding syndrome compared to those with other types of  epilepsy (Fisher’s Exact Test,
p=0.083). Contrary to skin PCR results, PCR of CSF was negative in all patients.
Conclusion: The observed trend towards an association of  intraparenchymal cerebral pathological results on MRI and a
positive skin PCR for O. volvulus despite negative PCR of  CSF is intriguing and deserves further attention.
Key words: Epilepsy, head nodding, magnetic resonance imaging, cerebrospinal fluid. Onchocerca volvulus
African Health Sciences 2013; 13(2): 529  - 540 http://dx.doi.org/10.4314/ahs.v13i2.51
*Corresponding author:
Dr. Andrea Sylivia Winkler
Department of  Neurology
Klinikum rechts der Isar





The discussion whether onchocerciasis causes
epilepsy still remains to be resolved and lately has
taken a new direction in search for causes of a
devastating African epidemic epilepsy syndrome
termed nodding syndrome (NS).1-4 Human
onchocerciasis is caused by the filarial nematode
Onchocerca volvulus (O. volvulus), which mainly manifests
on skin and eyes.5,6 The blackfly (Simulium species)
transmits the microfilariae (mf) during a blood meal.
In the host they grow into adult worms, which again
mate and produce mf. These mf mainly migrate in
subcutaneous tissue and may occasionally be found
in sputum, urine, blood, and cerebrospinal fluid
(CSF).7,8 In African areas affected by onchocerciasis,
some studies suggest a connection with epilepsy,9-14
while others do not.15-17 Overall a link between the
two diseases seems possible,18,19 but is far from being
established. Latest results on NS from South Sudan
indicate that in some villages significantly more
children with NS are infested with O. volvulus
compared to healthy controls, whereas in other
villages no difference could be found between cases
and controls.3
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One hypothesis is that mf may cause
inflammation or direct destruction of brain tissue
similar to the mechanisms known from the analysis
of affected skin and eyes20. Therefore imaging studies
may shed some more light on the debate whether there
is a causal relationship between epilepsy and O. volvulus.
The area (Mahenge) of  southern Tanzania where the
study took place has a prevalence of epilepsy of up
to 37.1/1,000,21 the prevalence rates of epilepsy in
sub-Saharan Africa ranging from 7.8-14.8/1,000,22 and
in addition, is highly endemic for onchocerciasis.23
Thus, it was deemed appropriate to recruit people with
epilepsy (PWE) from this region for parasitological
and neuroradiological work-up. To elucidate such a
potential association between O. volvulus and epilepsy,
we performed, for the first time, both cerebral MRI
in PWE and children/adolescents with NS from an
area endemic for O. volvulus together with O. volvulus
polymerase chain reaction (PCR) of  skin and CSF.
Methods
Study sites and performance of  MRI
The main study was conducted in The Mahenge
Epilepsy Clinic, which was founded in 1960 by L. Jilek-
Aall, nowadays attended by well over 900 people with
epilepsy.24 It is situated in the Government Hospital
of Mahenge which cares for an approximate 32,000
inhabitants of the Vigoi division, Ulanga district,
southern Tanzania. Although Mahenge, our study area,
has been part of the African Programme for
Onchocerciasis Control (APOC) since 1997, in 2011
an epidemiological survey revealed that the prevalence
of onchocerciasis was still 46% (personal
communication Elibariki Mwakapeje, Ministry of
Health Tanzania).
The MRI scans were performed in the
Department of  Radiology at The Aga Khan Hospital,
Dar es Salaam, 500 km away from Mahenge, using a
1.5 Tesla MR machine (GE). In all patients, axial T1W1,
T2W1, FLAIR, coronal FLAIR, and sagittal T1W1
were performed. In selected patients (especially those
patients with complex partial seizures or head nodding
seizures), coronal T2W1 and coronal 3D SPGR for
hippocampus anatomy was added. All scans were
evaluated by three experienced radiologists (JD, SV
and TG), who were blinded to the patient groups.
Participants and data collection
A convenience sample of patients known to suffer
from epilepsy or NS was recruited from The Mahenge
Epilepsy Clinic in order to evaluate whether in these
people brain lesions on MRI were associated with a
positive evidence for onchocerciasis. All PWE or NS
had active epilepsy with at least one seizure in the
year preceding the survey. Patients with single epileptic
seizures or epileptic seizures with an obvious
predisposition or cause (e.g. perinatal brain damage,
seizures in the context of malaria or alcohol withdrawal
seizures among others) were excluded. Epilepsy was
defined as two or more afebrile seizures unrelated to
acute metabolic disorders or withdrawal of drugs or
alcohol.25 For the definition of  NS refer to Winkler et
al..1 The actual head nodding seizure represents a
repetitive short loss of neck muscle tone resulting in
a forward bobbing of the head unexplained by any
other neurological or psychiatric condition. In addition
to the actual nodding seizures there may be other
seizure types and/or neurological/medical signs/
symptoms present which has been suggested as early
as 2008 to be termed nodding syndrome (=NS).1
A previously validated questionnaire was used
in a face-to-face interview performed by neurologists
(WM, ES, ASW), final-year medical students on elective
attachment from the University of  Innsbruck (KF,
MM), a translator, at least one relative and the patient.
Physical examination with neurological evaluation was
also performed (WM, ES, ASW). An
electroencephalogram (EEG) was not at hand. In
terms of  recruitment of  participants we aimed for an
even distribution of people with seemingly epilepsy
without focal signs (group1) and epilepsy with focal
signs (group 2), and within these two groups we aimed
for similar ages, a balanced distribution of gender and
people with O. volvulus positive and negative skin snips.
Patients of group 1 suffered from generalized tonic-
clonic seizures and were neurologically and mentally
normal. People with epileptic seizures (either focal or
generalized based on ictal observation) with clear focal
neurological signs and/or clear mental handicap/
cognitive impairment having been present before the
onset of  seizures were put into group 2. Alternatively,
if on neurological and standard cognitive examination
no abnormality was detected, patients with clear focal
types of epilepsy but otherwise healthy were also put
into this group. Patients with NS were allocated to a
separate group (group 3) and divided into “head
nodding only” and “head nodding plus” in order to
reflect the full spectrum of disease1. The groups are
summarized as follows:
Patient groups
Group 1 (n=10): Epilepsy without obvious focal
neurological signs/mental retardation
Group 2 (n=10): Epilepsy with obvious focal
neurological signs/mental retardation, or clear focal
epilepsy (based on ictal observations) without any of
the mentioned signs
Group 3 (n=12): Head nodding seizures, divided in:
a)Head nodding only” with head nodding seizures only
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b) «Head nodding plus” with head nodding seizures
and other seizure types mainly generalized tonic-clonic
seizures.
Laboratory procedures
Skin snips were taken from the right and left iliac
crest. If  there were skin changes suggestive of  O.
volvulus, a skin snip was taken from that site too.
Microscopic evaluation of  mf  was performed at 40x
magnification one and four hours later. If  no mf  was
seen, the well was checked again after 12 hours. The
mf  density per person was calculated. The O. volvulus
PCR was performed after a modified version of  that
used by Zhang et al.26 Methods were optimized, quality
controls and specificity tests with different parasites
were performed to exclude cross reactivity. Gel
electrophoresis was applied to visualize the
amplification products. The PCR for O. volvulus in CSF
was performed according to the method used for skin
snips. Infestation with O. volvulus was established in
the presence of a positive skin PCR. In four cases
PCR was not performed. In these cases the results on
skin snip were observed.
 
Ethical clearance
The study was cleared by the Ethics Committee of
the Muhimbili University College of Health Sciences,
University of  Dar es Salaam. Oral informed consent
was given by all patients allowing us to transcribe
clinical data into the questionnaire. Written and
witnessed informed consent was obtained from the
patients or, in case of children or non-competent




The data was analysed using SPSS 18.0 (SPSS Inc.,
Chicago, USA). The chi square-test and Fischer’s Exact
test were used to test the association between two
categorical variables. The Mann-Whitney U test was
performed for continuous variables with a non-
parametric distribution; the significance level was set
at alpha=0.05. As this is a hypothesis generating
investigation, no adjustment for multiple testing was
applied. Furthermore, in view of  the small group sizes,
no multivariate analyses were carried out.
Results
Demographic, clinical and laboratory details
The median age of all 32 patients was 16 years
(interquartile range (IQR): 14-21 years) with a male
to female ratio of 1.3:1. Along with demographic,
clinical and imaging details, the average densities of
the O. volvulus mf  in the skin and the results of  the
respective PCR are presented in tables 2 - 4. In three
cases, no further counting of mf was available, thus
only information as to whether the skin snip was
positive or negative is given. The skin snips of 28/32
patients were retested for O. volvulus antigen by PCR.
Five patients had a positive skin PCR despite a negative
skin snip and on the other hand, three patients had a
negative skin PCR despite a positive skin snip. The
CSF PCR, the results of which are not presented in
the tables, was performed in all patients and was
negative in all of them.
 
Results of the MRI investigations
Normal cerebral MRI scans were found in 10/32
patients (31.3%). Table 1 gives an overview of  the
diagnosed cerebral lesions.
Table 1: Pathologies on MRI scans divided into unilateral and bilateral lesions
Pathologies                 Unilateral         Bilateral       Total
 lesions  lesions
HC changes* 3 6 9
Gliotic lesions** 4 2 6
Signal abnormalities*** 0 3 3
Cyst 2 0 2
Other lesions**** 1 1 2
Total 10 12 22
Atrophy N.A. N.A. 12
No biopsies                -                            -                   10
MRI could show more than one pathology. HC – Hippocampus, N.A. – not applicable
*Gliotic lesions were defined as focal small (< 1cm) punctuate hyperintensities in T2W1, mainly located in the
frontal  lobe;  **HC changes were divided into HC sclerosis and suspected HC sclerosis, the latter only showing
either HC signal change or volume loss; ***Signal abnormalities were defined as subcortical hyperintensities
that did not fulfil the criteria for gliotic lesions
****Other lesions: focal cortical dysplasia, bilateral cystic lesions in the occipital lobe
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Table 2 : Demographics, neurological examination, MRI, mf  density and skin PCR of  group 1
Age  Gender  Seizure  Neurological          Intraparenchymal Atrophy Mf skin /mg  PCR skin
 (yrs)     type       examination/ MRI  pathologies
 mental exami-
nation
12 M Gen NAD Susp. HC sclerosis lft No 6 Pos
17 M Gen NAD Cortical dysplasia lft No 51.5 Pos
frontal
20 M Gen NAD Signal abnorm.  bilateral General 11.5 Pos
peritrigonal
21 F Gen NAD Gliotic lesions subcortical No 1.33 Pos
rt frontal
35 F Gen NAD No No Pos* Pos
16 F Gen NAD No Mild general 0 Neg
18 M Gen NAD No No 0 Pos
20 F Gen NAD No No 0 Neg
21 M Gen NAD No No 0 Neg
32 M Gen NAD No General 0 Neg
Gen – generalized tonic clonic seizures, NAD – nothing abnormal detected,  rt – right, lft- left, susp. – suspected,
abnorm. – abnormalities, Mf  – microfilariae, pos* - no further counting available
In group 3, consisting of  patients with NS,
four patients (33.3%) with head nodding alone showed
normal MRI scans. The remaining eight patients, the
majority of which suffered from NS together with
generalized tonic clonic seizures, showed gliotic lesions
(5/8; figures 1a-6a) and hippocampus pathologies (4/
8), among other lesions (table 4).
Relationship between results on MRI and types
of epilepsy (subgroup analysis)
The presence of intraparenchymal pathologies on
MRI (exclusive of cerebral atrophy) was not dependent
on the patients’ age (Mann-Whitney U test, p=0.985)
or gender (c2-test, p=0.530). Regarding types of
epilepsy, relevant intraparenchymal MRI pathologies
such as hippocampus changes, gliotic lesions and signal
abnormalities, were significantly more frequent  in the
group “head nodding plus with other seizure types”
compared to the other types of  epilepsy (Fisher’s Exact
Test, p=0.01; table 4). When looking at specific brain
lesions, the significance could be maintained for gliotic
lesions only (Fisher’s Exact Test, p=0.034; figures 1a-
6a).
In group 2, two patients had normal MRI,
one without pathological findings on neurological and
mental examination and the other with slight mental
retardation. All other patients had pathological MRI
results which together with the clinical examination,
mf density and skin PCR are shown in table 3. The
most frequent intraparenchymal cerebral pathologies
were signal changes in the hippocampus followed by
subcortical signal abnormalities (table 3).
Of the 32 patients, nine patients (28.1%) showed
changes in the hippocampus, six of  them bilaterally.
Sclerosis was confirmed in only three patients, the
others had either signal changes or loss of volume in
the hippocampus. Clinically 3/9 patients had complex
partial or generalized tonic clonic seizures with focal
signs, 4/9 had nodding seizures either alone or
associated with other seizure types and one patient
had generalized tonic clonic seizures without focal signs.
Only three patients with hippocampus changes
reported febrile seizures in childhood. Six patients
(18.8%) had gliotic lesions, mainly subcortically, and
three patients (9.4%) showed bilateral peritrigonal/
subcortical signal abnormalities.In two patients (6.3%)
an arachnoid cyst was found, one in the frontal lobe
measuring 20x14 mm, the other in the temporal lobe
being much smaller in size. A focal cortical dysplasia
in the frontal lobe and a bilateral cystic lesion in the
occipital lobes, the latter most likely caused by perinatal
hypoxic brain damage, were seen in one patient each.
Atrophy of the brain was found in 12/32 patients
(37.5%) and was the only pathological finding in four
of them. Cerebral and cerebellar atrophy were equally
distributed (tables 1-4).
In group 1, four patients showed intracerebral
pathologies on MRI. Unilateral gliotic lesions, focal
cortical dysplasia and bilateral signal abnormalities were
seen as well as unilateral hippocampus changes (table
2).
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Table 3: Demographics, neurological examination, MRI, mf  density and skin PCR of  group 2
Age   Gender  Seizure Neurological examin-       Intraparenc- Atrophy Mf skin  PCR
(yrs)    type ation/ mental examin- hymal MRI path- /mg skin
ation ologies
14 F 1.Gen+, NAD No No 0.5 Not
2.Cp                    tested
16 M Gen MeRe, no focal neurol- No Cerebellar 4 Neg
ogical signs  vermis
18 F Gen MeRe, no focal neurol- Arachnoid cyst rt frontal  No 35.5 Pos
ogical signs
22 M Gen+ MeRe,hemihypaesthesia Susp. HC sclerosis bilateral Mild 0.17 Pos
rt, UMN signs rt general
47 M 1.Gen, NAD HC sclerosis lft, susp. Cerebellar 5.5 Pos
no focal HC sclerosis rt; signal
neurological abnorm. subcortical bilateral
signs  frontal
13 F Cp MeRe, no focal neurol- No No 0 Pos
ogical signs
13 M 1.Gen, MeRe, no focal neurol- Signal abnorm. subcortical No 0 Neg
2.Cp ogical signs bilateral occipital
15 M Gen MeRe, cerebellar syndrome Cystic defects occipital Cerebellar 0 Neg
bilateral
16 M Gen MeRe, increased reflexes No Mild cere- 0 Neg
bellar
27 F Gen+ NAD Susp. HC sclerosis bilateral Cerebral 0 Neg
                                                  occipital +
                                                                                                                                         parietal
Cp - complex partial seizures, Gen - generalized tonic clonic seizures, Gen+ - generalized tonic clonic seizures with additional focal
signs ictally, NAD – nothing abnormal detected, MeRe - mental retardation, UMN - upper motor neuron, HC – Hippocampus, lft
– left, rt – right, susp. – suspected, abnorm. – abnormalities, Mf  – microfilariae, HC changes were divided into HC sclerosis and
suspected HC sclerosis, the latter only showing either HC signal changes or volume loss.
Table 4: Demographics, neurological examination, MRI, mf  density and skin PCR of  group 3
Age Gender Seizure Neurological examinat-   Intraparenchymal Atrophy Mf         PCR skin
(yrs) type ion/mental examination   MRI pathologies                              skin /mg
15 M HN only NAD No No 1.5 Neg
16 F HN only NAD Gliotic lesions rt frontal   No 5.65 Pos
subcortical; susp. HC
sclerosis rt>lft
18 M HN only Frontal release signs, No No 1 Neg
UMN signs lft>rt
10 F HN only NAD No No 0 Not tested
14 F HN only NAD No No Neg* Not tested
15 M HN only NAD Arachn cyst rt No 0 Pos
                                              temporal; HC sclerosis rt
9 F HN only UMN signs rt Gliotic lesions rt frontal  General Pos* Not tested
subcortical; susp. HC
sclerosis  rt>lft
15 M 1.HN, NAD Gliotic lesions bilateral No 1.5 Pos
2.Gen lft>rt frontal subcortical
16 F 1.HN, NAD Gliotic lesions lft temp-   No 6.17 Pos
2.Gen oral-occipital-parietal
gwm-j
13 M 1.HN, NAD Gliotic lesions bilateral No 0 Neg
2.Gen frontal subcortical
16 F 1.HN, NAD Susp.  HC sclerosis lft 0 Pos
2.Gen Mild cerebellar
21 M 1.HN, Brain damage, no focal Susp. HC sclerosis Mild 0 Pos
2.Gen,  neurology bilateral cerebellar
 3.Cp
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Footnotes for table 4
HN – head nodding seizures, Gen - generalized tonic clonic seizures, Cp - complex partial seizures, NAD –
nothing abnormal detected, HC – Hippocampus, susp. – suspected, gwm-j - grey-white matter junction, rt –
right, lft – left, neg*, pos* - no further counting available
Figure 1a T2W1
     Figure 2a-b FLAIR
HC changes were divided into HC sclerosis and suspected HC sclerosis, the latter only showing either HC
signal changes or volume loss.
Figure 3a T1W1 post contrast
Figures 1a – 3a: 13 year-old male with head nodding and generalized tonic clonic seizures showing bilateral
punctuate subcortical hyperintensities in the frontal lobe on T2W1. Some of them are suppressed on FLAIR
confirming that they are Virchow-Robin spaces, the remaining hyperintense foci most likely correspond to
gliotic lesions. After administration of  contrast medium, lesions were non-enhancing on T1W1.
Figure 4a T2W1
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Figure 5a Figure 5b
Figure 5c
Figure 5a-c FLAIR
Figure 6a T1W1 without contrast
Figures 4a – 6a: 14 year-old male with head nodding and generalized tonic clonic seizures showing bilateral
punctuate subcortical hyperintensities in the frontal lobe, on T2W1 and axial as well as coronal FLAIR most
likely corresponding to gliotic lesions
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Relationship between results on MRI and
infestation with O. volvulus
Patients with an abnormal MRI had significantly more
positive skin PCR results (Fisher’s Exact Test
p=0.019) than patients with a normal MRI (exclusive
of atrophy). When looking at plausible lesions that
could be caused by O. volvulus including gliotic lesions,
hippocampus changes or signal abnormalities there
was a near significant trend for these lesions to be
associated with a positive PCR results (Fisher’s Exact
Test p=0.067). Interestingly, when looking at epilepsy
types, it was only in people with head nodding that
the trend towards an association of intraparenchymal
pathologies on MRI with a positive skin PCR for O.
volvulus was seen (Fisher’s Exact Test, p=0.083; table
4).
When all three types of lesions were further analysed
separately the association could not be maintained.
 
Discussion
Our findings in general
The International League Against Epilepsy has
recommended neuroimaging with MRI for all PWE
wherever feasible.27 Availability and affordability are
rendering this recommendation almost impossible
in resource-poor countries. Excluding South Africa,
only nine MRI scanners were available in sub-Saharan
countries in 2003.28 CT scans are less expensive and
more widely-spread; in 2003 65 CT were registered
throughout sub-Saharan Africa.28 Thus, imaging
studies in PWE in sub-SaharanAfrica are scarce and
were mainly performed by means of  CT.29,30 In our
study, we performed 32 MRI scans in PWE with
different types of epilepsies including children/
adolescents with NS with and without additional
types of  seizures. Parts of  the findings in children/
adolescents with NS were already summarized in
the description of the study population in 2008,  figure
1 and are now presented more in depth and in the
wider context of  other types of  epileptic seizures.
Only 10 (31%) PWE of our study
population showed no abnormality on MRI. This is
highly different from studies from Brazil in which
76% of  over 130 PWE had normal MRI scans figure
3 and from Nigeria in which almost 50% of PWE
had a normal CT scans.30 The reason for the high
number of  abnormalities in our study might be
explained by selection bias. The patients of  our study
with normal MRI were mainly suffering from
epilepsy without any obvious neurological signs
(group 1), emphasizing the fact that thorough history
taking associated with clinical examination is a good
indicator for the type of epilepsy in resource-poor
settings.
In the individuals with pathological MRI
scans, atrophy, hippocampus changes and gliotic
lesions were the commonest findings. In some
patients, the atrophy was disproportionate for age.
Atrophy of the cerebellum may be explained by high
doses of phenytoin over many years and cerebral
atrophy by excessive alcohol use. Changes in the
hippocampus were seen in over 20% of PWE, which
may cause complex partial seizures, including head
nodding in children.32 Interestingly, all but one PWE
with hippocampus changes in our study had seizures
in the context of  either focal epilepsy or NS. In our
study, no significant relationship between febrile
convulsions and hippocampus changes was found.
Febrile seizures have however been identified as risk
factors of childhood epilepsy in other African
studies.33-35 Gliotic lesions were mainly found in
children and adolescents with head nodding,
especially in those with additional seizure types. Cranial
infections, cerebral ischemia and traumatic brain injury
have all been implicated as possible causes for gliotic
lesions in a study from China where 60% of people
with gliotic lesions were suffering from epilepsy.36
There was no history of trauma in the people of
our study. Ischemia especially in younger people seems
unlikely, so that an inflammatory cause for the gliotic
lesions seems possible.
 
MRI findings and O. volvulus
Electroencephalographic studies in PWE from an
area endemic for O. volvulus with high prevalence of
epilepsy showed mainly focal epileptiform activity.37
Focal lesions/pathologies were also prevalent in our
study population mainly consisting of gliotic lesions
and hippocampus changes. They were not evenly
distributed over the three study groups, but seemed
to be clustering in PWE with clinical indicators
pointing to focal epilepsy and in children/adolescents
with NS, especially those suffering from NS and
additional types of  seizures. Hippocampus changes
seem rather difficult to attribute to an infectious agent
but have been implicated in the context of
neurocysticercosis caused by the parasite Taenia
solium,38 whereas gliotic changes may be attributed
to inflammation.36 Mf migrating into the brain may
cause focal inflammatory reaction and subsequent
gliosis as has been shown with Loa loa, a filarial
nematode mainly distributed in West and Central
Africa. L. loa adult worms have been found to be
able to enter the brain causing an acute and severe
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encephalopathy mainly in O. volvulus co-infected
individuals treated with filaricidal drugs. Occasional
cases were reported, but are rare in comparison to
the number of individuals affected by L. loa .39
Pathological changes in L. loa encephalopathy include
inflammatory infiltrates and gliotic lesions in brain
parenchyma of  various degrees of  severity.40 In
addition to direct damage to brain parenchyma
affection of cerebral arteries (cellular infiltrates and
thickening of the vessel wall) has also be seen
observed40 which may lead to potentially ensuing
vasculitis that has also been demonstrated with other
parasites such as Toxocara canis.41
Duke et al.8 reported O. volvulus mf  in CSF
before and after treatment with diethylcarbamazine.
If this is a genuine finding and was not due to
contamination during lumbar puncture, the CSF
should have shown some signs of contact with the
parasites. Unfortunately, this was not described in
Duke’s study. In our study, O. volvulus PCR of  CSF
was negative in all individuals. It may be argued that
if  the inflammation caused by mf  had resolved, O.
volvulus PCR, which traces DNA and thus an active
process, may become negative. Interestingly, in
patients of  a much bigger patient cohort of  almost
200 PWE of which PWE of the current study were
part of, O. volvulus CSF antibody index, which should
give evidence of exposure to the parasite, was
negative too, indicating that contact of  the CSF with
the parasite, past or present, seems very unlikely.42
Gliotic lesions or other types of  signal abnormalities
may also be seen in an autoimmune response. Gallin
et al.43 have demonstrated an association between a
hyperreactive onchodermatitis and the presence of
autoantibodies to proteins found in neutrophils in
affected individuals. Also, an autoimmune process
has been hypothesized in the development of ocular
onchocerciasis and a shared antigen (OV39) between
ocular tissue, including the retina, and O. volvulus has
been implicated in the disease process.44,45 Based on
these principles, cross-reacting antibodies to nervous
tissue may be postulated.20,42 One would however
expect a completely different, at least more
widespread “gliotic” reaction if an autoimmune
pathogenesis caused by O. volvulus is assumed.
An indirect relationship between O. volvulus
and epilepsy might further be supported by the fact
that we found an almost significant association
between intraparenchymal pathologies on MRI and
O. volvulus PCR result on skin snip. Also, when looking
at the various types of epilepsy a nearly significant
relationship between brain pathologies, especially
gliosis and hippocampus changes, and positive skin
PCR could be maintained for children/adolescents
with NS only. Whether these lesions are causative
for the nodding seizures and/or the additional mainly
generalized seizures or whether they are unrelated
remains uncertain in the absence of  a control group.
Interictal EEG results in some of these children
showed generalized rather than focal abnormalities,1
which however does not exclude gliosis or
hippocampus changes as origin. As to the actual head
nodding attack, which clinically looks like atonic
seizures (and has recently been shown to be reflected
by an EEG decrement46) or, if nodding is less
prominent, complex partial or absence-type seizures,
gliosis as the cause of these attacks seem less likely
and in fact only 2/7 children with head nodding
attacks alone had gliotic lesions on MRI (table 4).
Hippocampus changes were seen in five of the 12
children/adolescents with NS and may cause
complex partial seizures in this cohort. However,
hippocampus changes were not more frequent than
in PWE with focal seizures and therefore may be an
accidental finding without implication for seizure
generation in children/adolescents with NS or,
alternatively, some of  the children/adolescents with
NS may indeed suffer from complex partial epilepsy
which clinically appears as head nodding.32
 
Limitations of the study
This is more of a descriptive study of MRI
pathologies in PWE and children/adolescents with
NS from an O. volvulus endemic area. In this context
statistical analysis of MRI pathologies and their
relationship with onchocerciasis must be interpreted
with care due to the small sample size. Local
circumstances with the only MRI in the country being
many hundreds of kilometers away and financial
restrictions did not allow for more people to be
recruited into the study. Also, the MRI (1.5 Tesla)
used in our study shows a fairly low resolution
compared to a 3 Tesla MRI and lesions may have
been missed. Neuroimaging in a larger population,
especially of  children/adolescents with NS, should
be envisaged in order to support or reject the trends
observed in our study. Also, our study is lacking a
control group of  healthy age-matched individuals.
Healthy young people in the circumstances of a
resource-poor setting can usually not be awayfor
several days as they are the backbone of their families
and indeed all the young people approached by us
did not consent to participate into our study.
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Conclusion
MRI in PWE and children/adolescents with HS from
an area endemic for O. volvulus shows multiple
pathologies, the most frequent being atrophy,
hippocampus changes and gliosis. There was a trend
towards an association of intraparenchymal brain
pathologies (hippocampus changes, gliotic lesions as
well as other signal abnormalities) and O. volvulus skin
PCR in PWE and more explicitly in children/
adolescents with NS. However, as this was a mere
observational study with low numbers and without
control group, the possible association between
certain brain pathologies and infection with O. volvulus
should be explored further, preferably in larger
studies with matched control groups.
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